Showing 37 to 48 of 153 results


FDA Requires New COVID-19 Vaccine Trials, CDC Offers Broader Access
The FDA requires new clinical trials for COVID-19 vaccines' effectiveness in healthy people under 65 before broader approval, while the CDC's immunization schedule includes them as an option, prompting questions about access and cost; insurance companies might demand medical documentation for covera...
FDA Requires New COVID-19 Vaccine Trials, CDC Offers Broader Access
The FDA requires new clinical trials for COVID-19 vaccines' effectiveness in healthy people under 65 before broader approval, while the CDC's immunization schedule includes them as an option, prompting questions about access and cost; insurance companies might demand medical documentation for covera...
Progress
52% Bias Score


Kennedy Urges Shift in Gender Dysphoria Treatment Protocols for Youth
HHS Secretary Robert F. Kennedy Jr. urged healthcare providers to use a controversial HHS report to update treatment protocols for gender dysphoria in youth, contradicting established medical consensus and prompting concerns about access to gender-affirming care.
Kennedy Urges Shift in Gender Dysphoria Treatment Protocols for Youth
HHS Secretary Robert F. Kennedy Jr. urged healthcare providers to use a controversial HHS report to update treatment protocols for gender dysphoria in youth, contradicting established medical consensus and prompting concerns about access to gender-affirming care.
Progress
56% Bias Score


France Eases Regulations for Non-EU Doctors
France's Ministry of Health announced new regulations streamlining the process for non-EU doctors to obtain licenses, creating a faster pathway for those already working in French hospitals, addressing previous complaints of a selective system that left many qualified doctors unable to practice desp...
France Eases Regulations for Non-EU Doctors
France's Ministry of Health announced new regulations streamlining the process for non-EU doctors to obtain licenses, creating a faster pathway for those already working in French hospitals, addressing previous complaints of a selective system that left many qualified doctors unable to practice desp...
Progress
36% Bias Score


U.S. Sends Envoy to Israel After Embassy Shooting
Following a terrorist attack in Washington D.C. that killed two Israeli Embassy staffers, Homeland Security Secretary Kristi Noem will travel to Israel Sunday night to show U.S. support, while the Justice Department investigates the suspect, Elias Rodriguez, and his potential ties to extremist group...
U.S. Sends Envoy to Israel After Embassy Shooting
Following a terrorist attack in Washington D.C. that killed two Israeli Embassy staffers, Homeland Security Secretary Kristi Noem will travel to Israel Sunday night to show U.S. support, while the Justice Department investigates the suspect, Elias Rodriguez, and his potential ties to extremist group...
Progress
52% Bias Score


France Amends End-of-Life Bill: Mandatory Collegial Consultation Required
The French National Assembly amended its end-of-life bill, requiring a mandatory collegial consultation involving at least a specialist and caregiver before approving an aid-in-dying request, replacing the initial requirement for written opinions. This change, adopted on May 22nd, aims for a more co...
France Amends End-of-Life Bill: Mandatory Collegial Consultation Required
The French National Assembly amended its end-of-life bill, requiring a mandatory collegial consultation involving at least a specialist and caregiver before approving an aid-in-dying request, replacing the initial requirement for written opinions. This change, adopted on May 22nd, aims for a more co...
Progress
32% Bias Score


UK Reviews Private Cross-Sex Hormone Prescriptions for Minors
The UK government is reviewing private cross-sex hormone prescriptions for under-18s following a High Court decision, with an expert panel reporting in July and the Health Secretary exploring legal options for private and overseas providers.
UK Reviews Private Cross-Sex Hormone Prescriptions for Minors
The UK government is reviewing private cross-sex hormone prescriptions for under-18s following a High Court decision, with an expert panel reporting in July and the Health Secretary exploring legal options for private and overseas providers.
Progress
44% Bias Score

German Medical Association Votes to Decriminalize Early-Term Abortions
The German Medical Association voted to decriminalize abortions up to 12 weeks, keeping mandatory counseling, aiming to improve patient care and legal clarity for doctors; this follows failed legislative attempts.

German Medical Association Votes to Decriminalize Early-Term Abortions
The German Medical Association voted to decriminalize abortions up to 12 weeks, keeping mandatory counseling, aiming to improve patient care and legal clarity for doctors; this follows failed legislative attempts.
Progress
36% Bias Score

HHS Urges Reconsideration of Gender-Affirming Care for Youth
HHS Secretary Robert F. Kennedy Jr. urged healthcare providers to adopt a controversial HHS report questioning the scientific basis of gender-affirming care for youth, prompting an HHS oversight initiative into hospitals performing such procedures and raising concerns about reduced access to care.

HHS Urges Reconsideration of Gender-Affirming Care for Youth
HHS Secretary Robert F. Kennedy Jr. urged healthcare providers to adopt a controversial HHS report questioning the scientific basis of gender-affirming care for youth, prompting an HHS oversight initiative into hospitals performing such procedures and raising concerns about reduced access to care.
Progress
64% Bias Score

Trump's "Most Favored Nation" Drug Pricing Policy Risks Stifling Innovation
President Trump's executive order mandates U.S. drug prices align with lower prices in other developed countries, potentially reducing research funding, delaying new drug launches, and increasing prices elsewhere, with minimal U.S. savings.

Trump's "Most Favored Nation" Drug Pricing Policy Risks Stifling Innovation
President Trump's executive order mandates U.S. drug prices align with lower prices in other developed countries, potentially reducing research funding, delaying new drug launches, and increasing prices elsewhere, with minimal U.S. savings.
Progress
60% Bias Score

Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump issued an executive order on May 12, 2025, aiming to lower U.S. prescription drug prices by increasing prices paid by foreign countries, facing legal and practical challenges while seeking to balance consumer benefits with pharmaceutical innovation.

Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump issued an executive order on May 12, 2025, aiming to lower U.S. prescription drug prices by increasing prices paid by foreign countries, facing legal and practical challenges while seeking to balance consumer benefits with pharmaceutical innovation.
Progress
56% Bias Score

France Formalizes Physician-Assisted Dying Procedure
The French National Assembly passed a law outlining procedures for physician-assisted dying, requiring requests to be made to an unrelated physician using written or adapted methods, excluding telehealth, and including provisions for psychological evaluations under certain circumstances.

France Formalizes Physician-Assisted Dying Procedure
The French National Assembly passed a law outlining procedures for physician-assisted dying, requiring requests to be made to an unrelated physician using written or adapted methods, excluding telehealth, and including provisions for psychological evaluations under certain circumstances.
Progress
36% Bias Score

Europe's Pharmaceutical Legislation: A Critical Juncture
Europe's pharmaceutical industry faces a critical decision regarding the General Pharmaceutical Legislation (GPL), with potential risks to its competitiveness and patient access to new treatments if it fails to modernize its regulatory framework, given that Europe's share of global R&D investment ha...

Europe's Pharmaceutical Legislation: A Critical Juncture
Europe's pharmaceutical industry faces a critical decision regarding the General Pharmaceutical Legislation (GPL), with potential risks to its competitiveness and patient access to new treatments if it fails to modernize its regulatory framework, given that Europe's share of global R&D investment ha...
Progress
60% Bias Score
Showing 37 to 48 of 153 results